CD36 and lung cancer: RNA-seq analyses of fusion hybrids – defined in this study as CD14+ cells also expressing CD36 and positive for pan-cytokeratins (PANK) – revealed expression of transcripts associated with cancer and expressed primarily in parent lung cancer cells, as well as transcripts involved in immune-associated pathways and expressed primarily in parent monocytes/macrophages.